We must not let protestors derail trials of pre-exposure prophylaxis for HIV.

by Joep M A Lange
Published 2005-09-01

Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection.

by Inge Derdelinckx, Mark A Wainberg, Joep M A Lange, Andrew Hill, Yasmin Halima, Charles A B Boucher
Published 2006-11-01

State of affairs of tuberculosis in prison facilities: a systematic review of screening practices and recommendations for best TB control.

by Natalie V S Vinkeles Melchers, Sabine L van Elsland, Joep M A Lange, Martien W Borgdorff, Jan van den Hombergh
Published 2013-01-01

Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.

by Philippe R Mutwa, Kimberly R Boer, Brenda Asiimwe-Kateera, Diane Tuyishimire, Narcisse Muganga, Joep M A Lange, Janneke van de Wijgert, Anita Asiimwe, Peter Reiss, Sibyl P M Geelen
Published 2014-01-01

Temporary treatment during primary HIV infection does not affect virologic response to subsequent long-term treatment.

by Marlous L Grijsen, Ferdinand W N M Wit, Suzanne Jurriaans, Frank P Kroon, Emile F Schippers, Peter Koopmans, Luuk Gras, Joep M A Lange, Jan M Prins, Primo-SHM Study Group
Published 2014-01-01

Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand

by Reshmie A. Ramautarsing, Nittaya Phanuphak, Surasith Chaithongwongwatthana, Ferdinand W.N.M. Wit, Nipat Teeratakulpisarn, Tippawan Pankam, Piyanee Rodbamrung, Joep M.A. Lange, Praphan Phanuphak, Vikrant V. Sahasrabuddhe, Stephen Kerr, Jintanat Ananworanich, Janneke H. Wijgert, van de
Published 2015-04-01

No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.

by Marlous L Grijsen, Radjin Steingrover, Ferdinand W N M Wit, Suzanne Jurriaans, Annelies Verbon, Kees Brinkman, Marchina E van der Ende, Robin Soetekouw, Frank de Wolf, Joep M A Lange, Hanneke Schuitemaker, Jan M Prins, Primo-SHM Study Group
Published 2012-01-01

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.

by Frank van Leth, Prahpan Phanuphak, Erik Stroes, Brian Gazzard, Pedro Cahn, François Raffi, Robin Wood, Mark Bloch, Christine Katlama, John J P Kastelein, Mauro Schechter, Robert L Murphy, Andrzej Horban, David B Hall, Joep M A Lange, Peter Reiss
Published 2004-10-01

Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities.

by Marleen E Hendriks, Ferdinand W N M Wit, Marijke T L Roos, Lizzy M Brewster, Tanimola M Akande, Ingrid H de Beer, Sayoki G Mfinanga, Amos M Kahwa, Peter Gatongi, Gert Van Rooy, Wendy Janssens, Judith Lammers, Berber Kramer, Igna Bonfrer, Esegiel Gaeb, Jacques van der Gaag, Tobias F Rinke de Wit, Joep M A Lange, Constance Schultsz
Published 2012-01-01